Benchmark Investment Advisors LLC Medtronic PLC Transaction History

Benchmark Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$76.72 - $87.58 $29,767 - $33,981	-388 Reduced 13.22%	2,548 $205,000
Q4 2022 Feb 21, 2023	SELL	$76.18 - $87.74 $71,075 - $81,861	-933 Reduced 24.11%	2,936 $228,000
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $276,811 - $326,722	-3,428 Reduced 46.98%	3,869 $312,000
Q2 2022 Aug 08, 2022	SELL	$87.4 - $113.09 $271,027 - $350,692	-3,101 Reduced 29.82%	7,297 $655,000
Q1 2022 May 16, 2022	BUY	$100.58 - $112.38 $78,552 - $87,768	781 Added 8.12%	10,398 $1.15 Million
Q4 2021 Feb 16, 2022	BUY	$99.53 - $127.75 $957,180 - $1.23 Million	9,617 New	9,617 $995,000

2,286

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $114B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Benchmark Investment Advisors LLC with notifications on news.